RNAi. Martin Latterich



Similar documents
RNAi Shooting the Messenger!

Protein Expression. A Practical Approach J. HIGGIN S

岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹

Lezioni Dipartimento di Oncologia Farmacologia Molecolare. RNA interference. Giovanna Damia 29 maggio 2006

TOOLS sirna and mirna. User guide

EXPRESSION ARREST shrna mir GENOME- WIDE LIBRARIES

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

Biosafety considerations of new dsrna molecules

Recombinant DNA and Biotechnology

Product: Expression Arrest TM egfp control shrna vector

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

Dicer Substrate RNAi Design

Von Mäusen und Menschen E - 1

MicroRNA formation. 4th International Symposium on Non-Surgical Contraceptive Methods of Pet Population Control

Understanding the immune response to bacterial infections

How to construct transgenic mice

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

An Overview of Cells and Cell Research

The world of non-coding RNA. Espen Enerly

Recombinant DNA Technology

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

Especially developed for the transfection of mammalian cells with sirna or mirna

GeneCopoeia Genome Editing Tools for Safe Harbor Integration in. Mice and Humans. Ed Davis, Liuqing Qian, Ruiqing li, Junsheng Zhou, and Jinkuo Zhang

An Introduction to Transfection Methods Technical Reference Guide

Outline. interfering RNA - What is dat? Brief history of RNA interference. What does it do? How does it work?

LONDON REGIONAL TRANSGENIC AND GENE TARGETING FACILITY

Manual for: sirna-trans Maximo Reagent

Engineering of Yellow Mosaic Virus Resistance (YMVR) in Blackgram. Project ID: 1 April 2000 to 31 August Project Duration:

sirna Duplexes & RNAi Explorer

Notch 1 -dependent regulation of cell fate in colorectal cancer

How to construct transgenic mice

RNA Viruses. A Practical Approac h. Alan J. Cann

Instructions. Torpedo sirna. Material. Important Guidelines. Specifications. Quality Control

How to construct transgenic mice

Trasposable elements: P elements

Cell Discovery 360: Explore more possibilities.

QIAGEN Transfection Technologies

Inhibition of MicroRNA Sensitizes 3D Breast Cancer Microtissues to Radiation Therapy

Bacterial Transformation with Green Fluorescent Protein. Table of Contents Fall 2012

How To Get A Cell Print

SureSilencing shrna Plasmids

!!!!!!!!!!!!!!!!!!!!!!!!!!

HiPerFect Transfection Reagent Handbook

Guidance. 2. Definitions. 1. Introduction

How many of you have checked out the web site on protein-dna interactions?

Diabetes and Drug Development

Primetime for KNIME:

Innate Immunity. Insects rely solely on an innate immune system for defense against infection

Micro RNAs: potentielle Biomarker für das. Blutspenderscreening

Mir-X mirna First-Strand Synthesis Kit User Manual

Thermo Scientific Dharmacon sirna Libraries

Germ cell formation / gametogenesis And Fertilisation

AP Biology Essential Knowledge Student Diagnostic

Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

RNA Structure and folding

Microarray Technology

BIOTECHNOLOGY OPERATIONS

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

ELITE Custom Antibody Services

1865 Discovery: Heredity Transmitted in Units

Accelerating drug development to FTIH: Potential of new expression technologies

Arabidopsis. A Practical Approach. Edited by ZOE A. WILSON Plant Science Division, School of Biological Sciences, University of Nottingham

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

Chapter 23 Definitions of GMO/LMO and modern biotechnology. Three different definitions but the same legal interpretation?

DNA Fingerprinting. Unless they are identical twins, individuals have unique DNA

The Leading Gene Through Screen CRO

LightSwitch Luciferase Assay System

Practical Cell Analysis

Assisted Reproductive Technologies at IGO

BioMmune Technologies Inc. Corporate Presentation 2015

PRODUCT INFORMATION...

Embryonic & and induced pluripotent Stem Cells. May 2010 Dipl. Biol. Dr. Kurt Pfannkuche

13.4 Gene Regulation and Expression

Supplemental Information. McBrayer et al. Supplemental Data

Functional RNAs; RNA catalysts, mirna,

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

Andrew F. Roberts, Ph.D. Deputy Director, CERA. September 19, 2013

MEF Starter Nucleofector Kit

Animal Cell Culture. Third Edition. A Practical Approach OXJORD VNIVVRSITY 1'RVSS

BLOCK-iT Products: Powerful tools to advance RNAi analysis

Genetic Engineering and Biotechnology

RNA: Transcription and Processing

RNA Interference. - Localization - Labeling - Expression Profiling - In Vivo Delivery - Transfection

Mouse ES Cell Nucleofector Kit

Gene Silencing Oligos (GSOs) Third Generation Antisense

Chapter 7. Physical interaction between Jamb and Jamc is necessary for myoblast fusion. Summary

Transcription:

RNAi Martin Latterich

Contributors Abbreviations Preface i x ( xi xiii 1 Methods in RNA interference 1 Martin Latterich and Dalia Halawan i References 2 2 RNAi reagent design 3 Bernd Jagla and Nathalie Aulner 2.1 Introduction 3 2.2 Lessons learned from X-ray structures/mechanism 4 2.3 Current design considerations 5 2.3.1 Asymmetry 5 2.3.2 Sequence positional preferences 6 2.3.3 Practical features 6 2.3.4 Non-sequence position-based considerations 6 2.3.5 shrna design considerations 8 2.4 Prediction tools 9 2.4.1 Other related tools 1 1 2.5 Databases 12 2.5.1 sirna databases 1 2 2.5.2 mirna databases 1 3 2.6 Target RNA secondary structure predictions 13 2.7 Other resources on the web 1 5 2.8 Concluding remarks 1 5 Acknowledgments 1 6 References 1 6 3 RNAi - a chemical perspective 2 1 Ouathek Ouerfell i 3.1 Background 2 1 3.2 Introduction 22 3.3 sirnas versus shrnas 22 3.3.1 sirnas 23 3.3.2 shrnas 23 3.4 RNAi reagents 23 3.5 RNA chemistry 24

3.6 RNA synthesis methods 2 4 3.7 High-throughput sirna synthesis: the full process 2 6 3.8 Summary and outlook 2 7 Acknowledgments 2 8 References 28 4 Validation of RNAi 3 1 Nathalie Aulner and Bernd Jagla 4.1 Introduction 3 1 4.2 sirna delivery 3 2 4.2.1 sirna transfection 3 2 4.2.2 Introduction of shrnas into mammalian cells 3 3 4.2.3 RNAi screening delivery systems 3 4 4.3 Silencing efficacy (potency) 3 5 4.3.1 Detection of mrna levels 36 4.3.2 Detection of protein levels 3 7 4.3.3 Detection of knockdown efficiency using a reporter system (surrogate assays) 38 4.4 Silencing validation 38 4.5 sirna specificity 39 4.6 Minimizing cell defense mechanism (dsrna interferon response) 40 4.7 Conclusion 4 1 Acknowledgments 42 References 4 2 5 RNAi libraries in dissecting molecular pathways of the human cell 47 Cheryl Eifert, Antonis Kourtidis and Douglas S. Conkli n 5.1 Introduction 4 7 5.2 RNAi 4 7 5.3 Approaches for loss-of-function screens 50 5.4 High-throughput RNAi screens 5 2 5.5 RNAi-induced phenotype selections 54 5.6 Screens for mirna functions 5 6 5.7 Perspectives in disease treatment 5 7 References 5 7 6 High-throughput RNAi in Caenorhabditis elegans - from molecular phenotypes to pathway analysis 6 5 Sarah Jenna and Eric Cheve t 6.1 Introduction 6 5 6.1.1 RNAi in C. elegans 6 5 6.1.2. High-throughput RNAi in C. elegans 6 6 6.2 The experiments 66 6.3 Summary 68 References 69 Protocol 6.1 : Generation of constructs driving RNAi through a feeding procedure 7 1 Protocol 6.2: RNAi treatment of GFP reporter animals 73 Protocol 6.3 : Sorting of fluorescent animals and measurement of the UPR 77

7 RNAi in Xenopus laevis 79 Adrianna L. Stromme and Craig A. Mandato 7.1 Introduction 79 7.2 Oocyte isolation 8 1 7.2.1 Inducing ovulation 8 1 7.2.2 Collecting eggs 8 1 7.3 Testes isolation 82 7.4 In vitro fertilization 8 2 7.5 Microinjecting dsrna into embryos/oocytes 82 7.5.1 Dejellying embryos 8 2 7.5.2 Vitelline membrane removal 8 3 7.5.3 Microinjections 8 3 7.6 Lineage labeling 8 4 7.6.1 Dextran amines 8 4 7.6.2 ß-Galactosidase RNA 8 4 7.6.3 GFP RNA as a lineage marker 84 7.7 Screening of phenotypes 8 5 References 8 5 Protocol 7.1 : Solutions appendix 8 6 Protocol 7.2: X-gal staining protocol (Sive et al., 1997) 8 8 Protocol 7.3: Overall protocol for sirna experiment (example) 8 9 8 Generation of transgenic and knockdown mice with lentiviral vectors and RNAi techniques 9 1 Jenni Huusko, Petri I. Mäkinen, Leena Alhonen and Seppo Ylä-Herttual a 8.1 Introduction 9 1 8.2 Production of transgenic and knockdown mice 9 1 8.3 Use of ES cells 9 1 8.4 Use of embryos 9 2 8.5 Lentivirus vectors 9 3 8.6 Design of LVs for the generation of knockdown mice 9 4 8.6.1 Constitutive pol III promoters 9 4 8.6.2 Regulatable pol III promoters 9 5 8.6.3 Pol II promoters 9 5 References 9 6 Protocol 8.1: Mice, reagents and equipment 9 9 Protocol 8.2: Setting up capillaries, injection needles, injection chambers an d preparations for transgenesis 10 2 Protocol 8.3: Direct microinjection of the viral construct to the subzonal spac e (= perivitelline space) of a fertilized egg cell 10 5 Protocol 8.4: Zona pellucida removal and lentiviral transduction 10 8 9 RNAi in fungi 11 3 Hitoshi Nakayashiki 9.1 Introduction 11 3 9.1.1 The discovery of quelling in Neurospora 11 3 9.1.2 Meiotic silencing by unpaired DNA (MSUD), a nove l gene-silencing phenomenon in Neurospora 11 3 9.1.3 RNAi as a genetic tool in fungi 114

9.2 RNAi strategies in fungi 11 6 9.2.1 RNAi using a hairpin RNA-expressing plasmid 11 6 9.2.2 RNAi using an opposing-dual promoter system 11 7 9.2.3 Direct delivery of dsrna into fungal cells 11 8 9.2.4 Simultaneous silencing of multiple genes 11 8 9.3 Genetic transformation and RNAi protocols for fungi 119 Acknowledgments 12 0 References 120 Protocol 9.1 : Transformation of Magnaporthe oryzae by the calcium chloride/polyethylene glycol (PEG) method 12 3 Protocol 9.2: Transformation of Cryptococcus neoformans by electroporation 12 5 Protocol 9.3: Transformation of Mortierella alpina by the microparticl e bombardment method 12 7 Protocol 9.4: Transformation of Phytophthora infestans by th e Lipofectin-mediated transfection method 12 9 Index 133